🍽️ phenelzine sulfate,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Antihistamine Effects: Pheniramine maleate works by blocking the action of histamine, a substance produced by the body during an allergic reaction. By inhibiting histamine activity, pheniramine helps alleviate symptoms such as sneezing, itching, watery eyes, and runny nose.

  2. Allergy Relief: Pheniramine maleate is commonly used to relieve symptoms of allergic rhinitis (hay fever), including nasal congestion, itching, and sneezing caused by exposure to allergens such as pollen, dust mites, or pet dander.

  3. Cold and Flu Relief: Pheniramine maleate is often included in over-the-counter cold and flu medications to alleviate symptoms such as nasal congestion, runny nose, and sneezing associated with upper respiratory tract infections.

  4. Sedative Effects: Pheniramine maleate has sedative properties and may cause drowsiness or sleepiness, especially at higher doses or when combined with other central nervous system depressants such as alcohol or certain medications. Patients should avoid activities requiring mental alertness, such as driving or operating machinery, until they know how pheniramine affects them.

  5. Dry Mouth: Pheniramine may cause dry mouth as a side effect, which can be bothersome for some individuals. Maintaining adequate hydration and using sugar-free lozenges or gum may help alleviate this symptom.

  6. Urinary Retention: Pheniramine can impair bladder function and lead to urinary retention, particularly in men with prostatic hypertrophy or individuals with pre-existing urinary issues. Patients should be monitored for urinary symptoms and advised to seek medical attention if they experience difficulty urinating.

  7. Blurred Vision: Pheniramine may cause temporary blurred vision or difficulty focusing, particularly at higher doses. Patients should use caution when performing tasks that require visual acuity, such as driving or reading, until their vision returns to normal.

  8. Gastrointestinal Effects: Gastrointestinal side effects such as nausea, vomiting, or stomach upset may occur with pheniramine use, although they are less common. Taking pheniramine with food may help minimize these effects.

  9. Skin Reactions: In rare cases, pheniramine may cause allergic skin reactions such as rash, itching, or hives. Patients should discontinue use and seek medical attention if they develop any signs of a severe allergic reaction.

  10. Drug Interactions: Pheniramine may interact with other medications, particularly other central nervous system depressants or drugs with anticholinergic properties, leading to additive effects on sedation or other side effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations   |   βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of phenelzine sulfate,(prescription) On Probiotics

Rank Probiotic Impact
species Escherichia coli Reduces

Bacteria Impacted by phenelzine sulfate,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Fusobacterium genus Decreases 👪 Source Study Periodontal disease, Lemierre syndrome, skin ulcers
Bacteroides genus Decreases 👪 Source Study
Segatella genus Decreases 👪 Source Study
Escherichia genus Decreases 👪 Source Study
Streptococcus genus Decreases 👪 Source Study
Roseburia genus Decreases 👪 Source Study
Phocaeicola genus Decreases 👪 Source Study
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
unclassified Negativicoccus no rank Decreases ⚗️ Source Study
Escherichia coli O80:H26 no rank Decreases 👶 Source Study
Eggerthellales order Decreases ⚗️ Source Study
Escherichia coli O145 serogroup Decreases 👶 Source Study
Escherichia coli O157 serogroup Decreases 👶 Source Study
Escherichia coli O26 serogroup Decreases 👶 Source Study
Escherichia coli O43 serogroup Decreases 👶 Source Study
Escherichia coli O1:H42 serotype Decreases 👶 Source Study
Escherichia coli O104:H4 serotype Decreases 👶 Source Study
Escherichia coli O121:H19 serotype Decreases 👶 Source Study
Escherichia coli O127:H6 serotype Decreases 👶 Source Study
Escherichia coli O139:H28 serotype Decreases 👶 Source Study
Escherichia coli O157:H7 serotype Decreases 👶 Source Study bloody diarrhea
Escherichia coli O44:H18 serotype Decreases 👶 Source Study
Escherichia coli O55:H7 serotype Decreases 👶 Source Study
Escherichia coli O6:H16 serotype Decreases 👶 Source Study
Escherichia coli O7:K1 serotype Decreases 👶 Source Study
Fusobacterium nucleatum species Decreases 📓 Source Study Infectious bacteria
Bacteroides fragilis species Decreases 📓 Source Study H02076 Bacteroides infection
Bacteroides ovatus species Decreases 📓 Source Study
Segatella copri species Decreases 📓 Source Study Over 70%ile Indicator of mycotoxin present
Escherichia coli species Decreases 📓 Source Study Diarrheal disease in children and travelers, Foodborne diarrhea outbreaks, hemorrhagic colitis, hemolytic-uremic syndrome
Anaerofustis stercorihominis species Decreases ⚗️ Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Negativicoccus sp. S5-A15 species Decreases ⚗️ Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
Pseudoflavonifractor capillosus species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
Streptococcus parasanguinis species Decreases 📓 Source Study
Roseburia intestinalis species Decreases 📓 Source Study
Phocaeicola vulgatus species Decreases 📓 Source Study
Coriobacterineae suborder Decreases ⚗️ Source Study
Fusobacterium nucleatum subsp. nucleatum subspecies Decreases 👶 Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of phenelzine sulfate,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
ADHD 0.9 0.9
Age-Related Macular Degeneration and Glaucoma 0 0
Allergic Rhinitis (Hay Fever) 0.4 0.4
Allergies 0.9 0.3 2
Allergy to milk products 0.5 0.1 4
Alzheimer's disease 2.2 1 1.2
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.8 0.2 3
Ankylosing spondylitis 0.7 0.7 0
Anorexia Nervosa 0.3 -0.3
Antiphospholipid syndrome (APS) 0.4 0.4
Asthma 0.3 -0.3
Atherosclerosis 0.4 0.1 3
Atrial fibrillation 0.3 0.7 -1.33
Autism 1.3 1.5 -0.15
Barrett esophagus cancer 0.4 0.1 3
benign prostatic hyperplasia 0.1 0.1
Bipolar Disorder 0.4 0 0
Brain Trauma 0.3 -0.3
Carcinoma 0.4 0.3 0.33
Celiac Disease 0.6 0.3 1
Cerebral Palsy 0.1 0.3 -2
Chronic Fatigue Syndrome 0.9 0.4 1.25
Chronic Kidney Disease 0.4 0 0
Chronic Lyme 0.3 -0.3
Chronic Obstructive Pulmonary Disease (COPD) 0.6 0 0
Chronic Urticaria (Hives) 0.4 1 -1.5
Coagulation / Micro clot triggering bacteria 0.4 0.1 3
Colorectal Cancer 2.5 2.5
Constipation 0.4 0 0
COVID-19 1.5 1.3 0.15
Crohn's Disease 2.5 1.4 0.79
cystic fibrosis 0.3 0.3 0
deep vein thrombosis 0.3 0.1 2
Depression 2 0.5 3
Dermatomyositis 0.1 0.1
Eczema 0.1 0.7 -6
Endometriosis 0.7 0.7
Eosinophilic Esophagitis 0.4 0.4
Epilepsy 1.5 0.3 4
Fibromyalgia 0 0.6 0
Functional constipation / chronic idiopathic constipation 1.9 1.3 0.46
gallstone disease (gsd) 0.1 0.4 -3
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 1.1 0.1 10
Generalized anxiety disorder 0.7 0.3 1.33
Glioblastoma 0.1 -0.1
Graves' disease 0.3 0 0
Halitosis 0.7 0.1 6
Hashimoto's thyroiditis 0.3 0.3 0
Hidradenitis Suppurativa 0.4 0.4
Histamine Issues,Mast Cell Issue, DAO Insufficiency 0.6 0.6
hyperglycemia 0.1 0.3 -2
hypertension (High Blood Pressure 0.4 1 -1.5
Hypoxia 0.3 0.3
IgA nephropathy (IgAN) 0.8 -0.8
Inflammatory Bowel Disease 1.3 1.4 -0.08
Insomnia 0.3 0.3 0
Intelligence 0.3 -0.3
Intracranial aneurysms 0.3 0.3
Irritable Bowel Syndrome 0.6 0.9 -0.5
Liver Cirrhosis 0.9 0.4 1.25
Long COVID 0.9 0.7 0.29
Low bone mineral density 0 0
Lung Cancer 0.1 0.1
ME/CFS with IBS 0.1 0.3 -2
ME/CFS without IBS 0.2 0.3 -0.5
Menopause 0.5 0.5
Metabolic Syndrome 1.8 1.5 0.2
Mood Disorders 2 0.5 3
multiple chemical sensitivity [MCS] 0.1 0.1
Multiple Sclerosis 0.6 1.4 -1.33
Multiple system atrophy (MSA) 0.1 0.1
Neuropathy (all types) 0.1 0.1 0
neuropsychiatric disorders (PANDAS, PANS) 0.2 0.2
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.5 0.3 0.67
Obesity 0.5 0.7 -0.4
obsessive-compulsive disorder 1.9 0.6 2.17
Osteoarthritis 0.4 0.4
Osteoporosis 0.4 0.3 0.33
pancreatic cancer 0.1 0.1
Parkinson's Disease 0.3 1.3 -3.33
Polycystic ovary syndrome 0.4 0 0
Psoriasis 0.9 0.7 0.29
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.6 1.4 0.14
Rosacea 0 0
Schizophrenia 0.3 0 0
Sjögren syndrome 0.5 0.3 0.67
Sleep Apnea 0.4 0.3 0.33
Small Intestinal Bacterial Overgrowth (SIBO) 0.7 0.7
Stress / posttraumatic stress disorder 0.9 0.3 2
Systemic Lupus Erythematosus 1.5 0 0
Tic Disorder 0.1 0.3 -2
Tourette syndrome 0.3 -0.3
Type 1 Diabetes 1.6 0.2 7
Type 2 Diabetes 1.8 1.7 0.06
Ulcerative colitis 0.7 1.2 -0.71
Unhealthy Ageing 2.2 0 0

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.